These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 25560847)

  • 1. Stress-related mucosal disease in the critically ill patient.
    Bardou M; Quenot JP; Barkun A
    Nat Rev Gastroenterol Hepatol; 2015 Feb; 12(2):98-107. PubMed ID: 25560847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial.
    Krag M; Perner A; Wetterslev J; Wise MP; Borthwick M; Bendel S; Pelosi P; Keus F; Guttormsen AB; Schefold JC; Møller MH;
    Trials; 2016 Apr; 17(1):205. PubMed ID: 27093939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.
    Alhazzani W; Alenezi F; Jaeschke RZ; Moayyedi P; Cook DJ
    Crit Care Med; 2013 Mar; 41(3):693-705. PubMed ID: 23318494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress-induced ulcer bleeding in critically ill patients.
    Ali T; Harty RF
    Gastroenterol Clin North Am; 2009 Jun; 38(2):245-65. PubMed ID: 19446257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What's new with stress ulcer prophylaxis in the ICU?
    Marker S; Krag M; Møller MH
    Intensive Care Med; 2017 Aug; 43(8):1132-1134. PubMed ID: 28238056
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-Effectiveness of Histamine
    Hammond DA; Kathe N; Shah A; Martin BC
    Pharmacotherapy; 2017 Jan; 37(1):43-53. PubMed ID: 27809338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and treatment of stress ulcers in critically ill patients.
    Yang YX; Lewis JD
    Semin Gastrointest Dis; 2003 Jan; 14(1):11-9. PubMed ID: 12610850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress ulcer prophylaxis in the intensive care unit: is it indicated? A topical systematic review.
    Krag M; Perner A; Wetterslev J; Møller MH
    Acta Anaesthesiol Scand; 2013 Aug; 57(7):835-47. PubMed ID: 23495933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prophylaxis for stress ulcer bleeding in the intensive care unit].
    Avendaño-Reyes JM; Jaramillo-Ramírez H
    Rev Gastroenterol Mex; 2014; 79(1):50-5. PubMed ID: 24629722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
    Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
    Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients.
    Stollman N; Metz DC
    J Crit Care; 2005 Mar; 20(1):35-45. PubMed ID: 16015515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress ulcer prophylaxis in critically ill patients: review of the evidence.
    Alhazzani W; Alshahrani M; Moayyedi P; Jaeschke R
    Pol Arch Med Wewn; 2012; 122(3):107-14. PubMed ID: 22354363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are Proton Pump Inhibitors More Effective Than Histamine-2-Receptor Antagonists for Stress Ulcer Prophylaxis in Critically Ill Patients? A Systematic Review and Meta-Analysis of Cohort Studies.
    He N; Yan Y; Su S; Ge Q; Zhai S
    Ann Pharmacother; 2022 Sep; 56(9):988-997. PubMed ID: 34971320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal bleeding prophylaxis for critically ill patients: a clinical practice guideline.
    Ye Z; Reintam Blaser A; Lytvyn L; Wang Y; Guyatt GH; Mikita JS; Roberts J; Agoritsas T; Bertschy S; Boroli F; Camsooksai J; Du B; Heen AF; Lu J; Mella JM; Vandvik PO; Wise R; Zheng Y; Liu L; Siemieniuk RAC
    BMJ; 2020 Jan; 368():l6722. PubMed ID: 31907223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cluster randomised, crossover, registry-embedded clinical trial of proton pump inhibitors versus histamine-2 receptor blockers for ulcer prophylaxis therapy in the intensive care unit (PEPTIC study): study protocol.
    Young PJ; Bagshaw SM; Forbes A; Nichol A; Wright SE; Bellomo R; Bailey MJ; Beasley RW; Eastwood GM; Festa M; Gattas D; van Haren F; Litton E; Mouncey PR; Navarra L; Pilcher D; Mackle DM; McArthur CJ; McGuinness SP; Saxena MK; Webb S; Rowan KM;
    Crit Care Resusc; 2018 Sep; 20(3):182-189. PubMed ID: 30153780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withholding Pantoprazole for Stress Ulcer Prophylaxis in Critically Ill Patients: A Pilot Randomized Clinical Trial and Meta-Analysis.
    Alhazzani W; Guyatt G; Alshahrani M; Deane AM; Marshall JC; Hall R; Muscedere J; English SW; Lauzier F; Thabane L; Arabi YM; Karachi T; Rochwerg B; Finfer S; Daneman N; Alshamsi F; Zytaruk N; Heel-Ansdell D; Cook D;
    Crit Care Med; 2017 Jul; 45(7):1121-1129. PubMed ID: 28459708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton-pump inhibitors for stress ulcer prophylaxis in critically ill patients.
    Jung R; MacLaren R
    Ann Pharmacother; 2002 Dec; 36(12):1929-37. PubMed ID: 12452757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress ulcer prophylaxis in the new millennium: a systematic review and meta-analysis.
    Marik PE; Vasu T; Hirani A; Pachinburavan M
    Crit Care Med; 2010 Nov; 38(11):2222-8. PubMed ID: 20711074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*.
    MacLaren R; Campbell J
    Crit Care Med; 2014 Apr; 42(4):809-15. PubMed ID: 24365863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea.
    Buendgens L; Bruensing J; Matthes M; Dückers H; Luedde T; Trautwein C; Tacke F; Koch A
    J Crit Care; 2014 Aug; 29(4):696.e11-5. PubMed ID: 24674763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.